AH

Akso Health Group

AHGHealthcareNASDAQ

Medical Distribution · Last scanned Oct 24, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$13.8M
-6.4% YoY
Net Income
-$18.7M
+86.2% YoY
EBITDA
-$1.6M
+8.2% YoY
Free Cash Flow
-$350.7M

Scan Results

Daily timeframe
2 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▼ RSI OverboughtRSI 85.9, above 70, stock may be overbought
Oct 19▼ RSI OverboughtRSI 84.0, above 70, stock may be overbought
About Akso Health Group

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. Valued at $1.11B, AHG is a small-cap name in its sector. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment, housewares, home appliances, and cost-saving promotions at petrol gas stations.

Where AHG stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, AHG finished 12.50% below its 150-day moving average ($1.52) and 12.50% below its 200-day moving average ($1.52). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is AHG overbought or oversold?

At the October 20, 2026 close, AHG's RSI(14) was 85.9, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.11B
EPS$-0.03
Beta-1.00
52W Change-23.6%
Dividend Yield0.00%
ROE-9.8%
Analysis

On the balance sheet, AHG has $171K in cash with $2.4M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow is running at -$350.7M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -9.8% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has been relatively flat, moving from $13.2M (2023) to $13.8M (2026).

AHG's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Akso Health Group carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Akso Health Group and its sector.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms